Genmab — Juni 2020
-
Genmab-direktør: Første fase 3-studie med epcoritamab ventes i år https://medwatch.dk/Medicinal___Biotek/article12211163.ece
-
-
Ved ikke om der er linket til denne men NICE siger nej til Dara-udfordrer https://medwatch.dk/Medicinal___Biotek/article12209730.ece
-
Den havde vi i går uden megen snak om det.
-
Netop Mcjean.

-
Har været væk fra dagens begivenheder. Kan dog konstatere, at algoerne har kørt showet siden kl. 14.
-
25% af dagens samlede omsætning røg igennem slutauktionen.
-
E L. Unfortunately, I don't have the stats right now. But it looks like a record.
-
The partnership brings Genmab "everything they sought and more," RBC Capital Markets analyst Kennen MacKay said in a note to clients. He kept his outperform rating on Genmab stock. https://www.investors.com/news/technology/cancer-treatment-genmab-abbvie-deal-billions/?src=A00220&yptr=yahoo
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
Der må snart være nogen som tillægger den pipe noget mere værdi.